Chris MacDonald

Chris MacDonald

InvestorPlace Contributor

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Why Are Chinese EV Stocks NIO, LI, XPEV Down Today?

By Chris MacDonald, InvestorPlace Contributor

Today, a series of significant headwinds are prevailing for Chinese EV stocks, as these companies all dip between 8% and 11% this afternoon.

Why Is Evaxion Biotech (EVAX) Stock Up Today?

By Chris MacDonald, InvestorPlace Contributor

Today's news that Evaxion Biotech has enrolled its first patient in a key clinical trial has sent shares of EVAX stock soaring today.

Why a 100 BPS Fed Rate Hike Could Crash the Stock Market!

By Chris MacDonald, InvestorPlace Contributor

Today's choppy price action in the market suggests investors are still undecided with regard to how aggressive the Fed will be this week.

Why Is Change Healthcare (CHNG) Stock Soaring Today?

By Chris MacDonald, InvestorPlace Contributor

Today, investors in Change Healthcare and CHNG stock are cheering a ruling from a US District judge that the company's merger is allowed.

3 5G Stocks Under $10 to Buy Before They Bottom

By Chris MacDonald, InvestorPlace Contributor

Here are three 5G stocks under $10 that may be worth a look for investors interested in playing this rapidly growing sector.

Load More